Interview mit Stephan Mumenthaler in PharmaBoardroom

Study on the competitiveness of Chemistry Pharma Life Sciences 2023

Guest commentary Handelszeitung: Director General Stephan Mumenthaler

Switzerland retains top spot in EU Innovation Scoreboard 2023

Guest commentary NZZ: Director General Stephan Mumenthaler

Saying YES to the implementation of the OECD minimum tax

WTO decision on TRIPS Agreement

Chemical and pharmaceutical industry as a driver of growth

Interview Stephan Mumenthaler: success factors to boost R&D

Swiss innovation needs an efficient patent system

WTO decision on TRIPS Agreement

Action plan: One Health approach to combating antimicrobial resistance

Overview and position on antibiotic resistance

Promoting research into new antibiotics - but how?

Containing resistances: Antibiotic monitoring in veterinary medicine